Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Azides | 8 | 2018 | 129 | 1.100 |
Why?
|
Caspase 3 | 8 | 2016 | 796 | 1.000 |
Why?
|
Positron-Emission Tomography | 25 | 2018 | 6270 | 0.980 |
Why?
|
Fluorine Radioisotopes | 9 | 2014 | 464 | 0.930 |
Why?
|
Apoptosis | 15 | 2018 | 9973 | 0.760 |
Why?
|
Radiopharmaceuticals | 15 | 2015 | 2757 | 0.700 |
Why?
|
Caspase 7 | 3 | 2015 | 53 | 0.630 |
Why?
|
Choline | 5 | 2016 | 472 | 0.490 |
Why?
|
rho GTP-Binding Proteins | 3 | 2005 | 301 | 0.490 |
Why?
|
Indoles | 5 | 2018 | 1845 | 0.480 |
Why?
|
Colonic Neoplasms | 7 | 2014 | 2533 | 0.420 |
Why?
|
Heterotrimeric GTP-Binding Proteins | 5 | 2006 | 94 | 0.410 |
Why?
|
Fluorodeoxyglucose F18 | 7 | 2016 | 2025 | 0.390 |
Why?
|
Choline Kinase | 2 | 2016 | 5 | 0.380 |
Why?
|
Cyclophosphamide | 2 | 2013 | 2198 | 0.380 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2013 | 645 | 0.350 |
Why?
|
Receptors, CXCR4 | 4 | 2014 | 735 | 0.350 |
Why?
|
rhoA GTP-Binding Protein | 4 | 2005 | 249 | 0.330 |
Why?
|
HCT116 Cells | 8 | 2018 | 408 | 0.330 |
Why?
|
Receptor, PAR-1 | 2 | 2005 | 114 | 0.320 |
Why?
|
Neoplasm Invasiveness | 10 | 2014 | 3681 | 0.320 |
Why?
|
Dideoxynucleosides | 3 | 2018 | 116 | 0.310 |
Why?
|
Semaphorin-3A | 1 | 2006 | 36 | 0.310 |
Why?
|
Neoplasms | 13 | 2016 | 20528 | 0.300 |
Why?
|
Cell Proliferation | 10 | 2018 | 10620 | 0.300 |
Why?
|
Isatin | 3 | 2012 | 5 | 0.300 |
Why?
|
Quinazolines | 4 | 2016 | 1408 | 0.290 |
Why?
|
Triazoles | 2 | 2010 | 915 | 0.260 |
Why?
|
Mice, Nude | 13 | 2018 | 3801 | 0.260 |
Why?
|
Ki-67 Antigen | 4 | 2016 | 628 | 0.260 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1124 | 0.240 |
Why?
|
Deuterium | 3 | 2012 | 112 | 0.230 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2018 | 3633 | 0.230 |
Why?
|
Aminopyridines | 2 | 2016 | 541 | 0.220 |
Why?
|
Receptors, Thrombin | 1 | 2002 | 137 | 0.210 |
Why?
|
Peptides, Cyclic | 2 | 2013 | 403 | 0.210 |
Why?
|
Gene Silencing | 2 | 2018 | 1606 | 0.200 |
Why?
|
Cell Line, Tumor | 19 | 2018 | 16736 | 0.200 |
Why?
|
Botulinum Toxins | 1 | 2002 | 187 | 0.190 |
Why?
|
Mice, Inbred BALB C | 13 | 2016 | 6641 | 0.190 |
Why?
|
Mice, Inbred C3H | 2 | 2013 | 1013 | 0.190 |
Why?
|
Radioactive Tracers | 4 | 2013 | 81 | 0.190 |
Why?
|
Peer Review, Health Care | 1 | 2019 | 78 | 0.170 |
Why?
|
Thymidine Kinase | 3 | 2014 | 298 | 0.170 |
Why?
|
Ubiquitin C | 1 | 2017 | 3 | 0.170 |
Why?
|
Neoplasms, Experimental | 3 | 2014 | 1323 | 0.170 |
Why?
|
Mice | 30 | 2018 | 80375 | 0.170 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 97 | 0.170 |
Why?
|
Diagnostic Imaging | 2 | 2016 | 3494 | 0.170 |
Why?
|
Enzyme Activation | 6 | 2018 | 3818 | 0.160 |
Why?
|
Animals | 42 | 2018 | 169420 | 0.160 |
Why?
|
Histone Code | 1 | 2018 | 162 | 0.160 |
Why?
|
Growth Substances | 4 | 2003 | 812 | 0.150 |
Why?
|
Quinolines | 2 | 2013 | 738 | 0.150 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2018 | 180 | 0.150 |
Why?
|
Neoplasm Proteins | 3 | 2018 | 3741 | 0.150 |
Why?
|
Pyridinium Compounds | 1 | 2016 | 82 | 0.150 |
Why?
|
Carbon Radioisotopes | 2 | 2012 | 612 | 0.140 |
Why?
|
Retinoblastoma Protein | 2 | 2018 | 698 | 0.140 |
Why?
|
Oncology Service, Hospital | 1 | 2016 | 57 | 0.140 |
Why?
|
Isotope Labeling | 2 | 2014 | 423 | 0.140 |
Why?
|
Antineoplastic Agents | 5 | 2018 | 13626 | 0.140 |
Why?
|
Peptides | 6 | 2013 | 4384 | 0.140 |
Why?
|
Heterochromatin | 1 | 2018 | 306 | 0.140 |
Why?
|
Radiology, Interventional | 1 | 2019 | 424 | 0.140 |
Why?
|
Teaching Rounds | 1 | 2019 | 227 | 0.140 |
Why?
|
Mucins | 3 | 2003 | 552 | 0.130 |
Why?
|
Pentanoic Acids | 1 | 2014 | 14 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2006 | 3493 | 0.130 |
Why?
|
Retinal Pigment Epithelium | 1 | 2018 | 287 | 0.130 |
Why?
|
Phosphatidylcholines | 1 | 2016 | 435 | 0.130 |
Why?
|
Oligodendroglia | 1 | 2018 | 512 | 0.130 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2018 | 354 | 0.130 |
Why?
|
Radiochemistry | 2 | 2012 | 60 | 0.130 |
Why?
|
Signal Transduction | 8 | 2018 | 23729 | 0.120 |
Why?
|
Genes, Tumor Suppressor | 1 | 2018 | 1092 | 0.120 |
Why?
|
Enzyme Inhibitors | 5 | 2008 | 3898 | 0.120 |
Why?
|
Glycogen | 1 | 2014 | 267 | 0.120 |
Why?
|
Integrin alphaVbeta3 | 1 | 2013 | 120 | 0.120 |
Why?
|
Guanylate Cyclase | 2 | 2005 | 211 | 0.120 |
Why?
|
Morpholines | 1 | 2016 | 572 | 0.120 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2012 | 51 | 0.120 |
Why?
|
Deoxyglucose | 1 | 2013 | 341 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2016 | 570 | 0.120 |
Why?
|
Muscle Proteins | 3 | 2003 | 1152 | 0.110 |
Why?
|
Ubiquitin | 1 | 2017 | 827 | 0.110 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 321 | 0.110 |
Why?
|
Neuropeptides | 3 | 2003 | 937 | 0.110 |
Why?
|
Drosophila Proteins | 1 | 2002 | 1752 | 0.110 |
Why?
|
Diphenylamine | 2 | 2009 | 52 | 0.110 |
Why?
|
Brain Neoplasms | 3 | 2018 | 8805 | 0.110 |
Why?
|
Oncogenes | 1 | 2018 | 1246 | 0.110 |
Why?
|
Thymidine | 1 | 2012 | 342 | 0.110 |
Why?
|
Substrate Specificity | 2 | 2016 | 1831 | 0.110 |
Why?
|
Cisplatin | 2 | 2009 | 1654 | 0.110 |
Why?
|
Radiology Department, Hospital | 1 | 2016 | 414 | 0.110 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 402 | 0.110 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 2985 | 0.110 |
Why?
|
Molecular Targeted Therapy | 3 | 2018 | 2824 | 0.110 |
Why?
|
Proteins | 4 | 2003 | 6070 | 0.110 |
Why?
|
Recombinant Fusion Proteins | 3 | 2018 | 3844 | 0.100 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2003 | 351 | 0.100 |
Why?
|
Dipeptides | 1 | 2013 | 409 | 0.100 |
Why?
|
Imidazoles | 2 | 2007 | 1250 | 0.100 |
Why?
|
Tumor Cells, Cultured | 5 | 2018 | 6484 | 0.100 |
Why?
|
Aminoquinolines | 1 | 2010 | 107 | 0.100 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2014 | 607 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2018 | 2947 | 0.100 |
Why?
|
Organometallic Compounds | 1 | 2013 | 660 | 0.100 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1292 | 0.090 |
Why?
|
Hydroxamic Acids | 1 | 2013 | 500 | 0.090 |
Why?
|
Learning | 1 | 2019 | 1603 | 0.090 |
Why?
|
Benzamides | 3 | 2013 | 1390 | 0.090 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2009 | 86 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2016 | 1162 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1842 | 0.090 |
Why?
|
Alkynes | 3 | 2015 | 313 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1 | 1 | 2009 | 198 | 0.090 |
Why?
|
Osteosarcoma | 1 | 2014 | 890 | 0.090 |
Why?
|
Protein Kinase Inhibitors | 4 | 2016 | 5412 | 0.090 |
Why?
|
Estrogen Receptor alpha | 1 | 2012 | 579 | 0.080 |
Why?
|
Humans | 50 | 2019 | 715777 | 0.080 |
Why?
|
Tissue Distribution | 4 | 2015 | 2399 | 0.080 |
Why?
|
Etoposide | 1 | 2009 | 628 | 0.080 |
Why?
|
Contrast Media | 3 | 2018 | 5276 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 289 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2013 | 750 | 0.080 |
Why?
|
Receptor, erbB-2 | 2 | 2016 | 2313 | 0.080 |
Why?
|
Blood Vessels | 1 | 2013 | 1154 | 0.080 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 790 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 963 | 0.080 |
Why?
|
rho-Associated Kinases | 2 | 2005 | 288 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2018 | 12539 | 0.080 |
Why?
|
Image Enhancement | 1 | 2018 | 2979 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 2096 | 0.080 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 346 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2018 | 3129 | 0.070 |
Why?
|
Biosensing Techniques | 1 | 2012 | 613 | 0.070 |
Why?
|
G-Protein-Coupled Receptor Kinase 1 | 1 | 2005 | 8 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 931 | 0.070 |
Why?
|
Osteonectin | 1 | 2005 | 34 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2018 | 3054 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2016 | 20062 | 0.070 |
Why?
|
Receptors, Antigen | 1 | 2005 | 53 | 0.070 |
Why?
|
Pyrimidines | 2 | 2015 | 2930 | 0.070 |
Why?
|
HT29 Cells | 1 | 2005 | 207 | 0.070 |
Why?
|
Receptors, Thromboxane | 2 | 2003 | 22 | 0.070 |
Why?
|
Virulence Factors, Bordetella | 2 | 2002 | 157 | 0.070 |
Why?
|
Pertussis Toxin | 2 | 2002 | 181 | 0.070 |
Why?
|
GTP-Binding Protein alpha Subunits, G12-G13 | 2 | 2002 | 42 | 0.070 |
Why?
|
Dogs | 3 | 2005 | 4046 | 0.070 |
Why?
|
Coiled Bodies | 1 | 2004 | 5 | 0.070 |
Why?
|
Intranuclear Inclusion Bodies | 1 | 2004 | 41 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2789 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2018 | 2225 | 0.070 |
Why?
|
Mutation | 7 | 2018 | 29291 | 0.070 |
Why?
|
Computer Simulation | 1 | 2018 | 6105 | 0.070 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2002 | 133 | 0.070 |
Why?
|
Cyclic GMP | 1 | 2005 | 414 | 0.060 |
Why?
|
Tenascin | 1 | 2004 | 55 | 0.060 |
Why?
|
Fibroblasts | 3 | 2018 | 4233 | 0.060 |
Why?
|
Cell Nucleolus | 1 | 2004 | 173 | 0.060 |
Why?
|
Sulfonamides | 2 | 2012 | 1923 | 0.060 |
Why?
|
Gallium Radioisotopes | 2 | 2014 | 152 | 0.060 |
Why?
|
Protein Binding | 3 | 2013 | 9559 | 0.060 |
Why?
|
Cell Compartmentation | 1 | 2004 | 422 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2011 | 6324 | 0.060 |
Why?
|
Blotting, Western | 4 | 2014 | 5379 | 0.060 |
Why?
|
rac GTP-Binding Proteins | 1 | 2004 | 171 | 0.060 |
Why?
|
Glioma | 1 | 2018 | 3302 | 0.060 |
Why?
|
Models, Biological | 3 | 2015 | 9809 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2016 | 8571 | 0.060 |
Why?
|
Glioblastoma | 1 | 2018 | 3346 | 0.060 |
Why?
|
Thrombin | 1 | 2005 | 605 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2014 | 3824 | 0.060 |
Why?
|
Muscle Cells | 1 | 2004 | 199 | 0.060 |
Why?
|
Cytokines | 1 | 2018 | 7190 | 0.060 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2006 | 652 | 0.060 |
Why?
|
Mitochondria | 1 | 2016 | 3613 | 0.060 |
Why?
|
Kidney | 5 | 2012 | 6881 | 0.060 |
Why?
|
Oncogene Protein pp60(v-src) | 1 | 2002 | 77 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9730 | 0.060 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1512 | 0.060 |
Why?
|
Hepatocyte Growth Factor | 1 | 2004 | 291 | 0.060 |
Why?
|
ADP Ribose Transferases | 1 | 2002 | 90 | 0.060 |
Why?
|
Cysteine | 1 | 2006 | 872 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2001 | 89 | 0.050 |
Why?
|
Proto-Oncogene Proteins pp60(c-src) | 1 | 2001 | 146 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2006 | 1311 | 0.050 |
Why?
|
Drug Stability | 2 | 2012 | 304 | 0.050 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 854 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 34430 | 0.050 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2003 | 285 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4751 | 0.050 |
Why?
|
Tamoxifen | 2 | 2018 | 992 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 4980 | 0.050 |
Why?
|
Isoenzymes | 2 | 2003 | 1803 | 0.050 |
Why?
|
Phosphorylation | 4 | 2016 | 8658 | 0.050 |
Why?
|
Female | 18 | 2018 | 377204 | 0.050 |
Why?
|
Cell Cycle | 3 | 2014 | 2993 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2012 | 4029 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2124 | 0.040 |
Why?
|
Forms and Records Control | 1 | 2019 | 161 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2647 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 4912 | 0.040 |
Why?
|
Genes, Retinoblastoma | 1 | 2018 | 139 | 0.040 |
Why?
|
Piperidines | 1 | 2006 | 1582 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2018 | 68 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2005 | 2977 | 0.040 |
Why?
|
Nucleosides | 1 | 2018 | 138 | 0.040 |
Why?
|
Sumoylation | 1 | 2018 | 84 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2018 | 5198 | 0.040 |
Why?
|
Chromosome Segregation | 1 | 2018 | 229 | 0.040 |
Why?
|
Heart Septal Defects | 1 | 2018 | 179 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9548 | 0.040 |
Why?
|
Citrate (si)-Synthase | 1 | 2016 | 45 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18199 | 0.040 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2018 | 356 | 0.040 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2016 | 94 | 0.040 |
Why?
|
Cell Movement | 2 | 2014 | 5397 | 0.040 |
Why?
|
Pyridines | 1 | 2007 | 2846 | 0.030 |
Why?
|
Transfection | 4 | 2009 | 6089 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2004 | 2995 | 0.030 |
Why?
|
Integrases | 1 | 2018 | 548 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2018 | 552 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2003 | 1403 | 0.030 |
Why?
|
Melanoma | 2 | 2012 | 5250 | 0.030 |
Why?
|
Comprehensive Health Care | 1 | 2016 | 129 | 0.030 |
Why?
|
Oxidation-Reduction | 2 | 2012 | 2299 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2018 | 830 | 0.030 |
Why?
|
Kinetics | 2 | 2013 | 6655 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2001 | 857 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2015 | 385 | 0.030 |
Why?
|
Lung | 1 | 2013 | 9735 | 0.030 |
Why?
|
Transgenes | 1 | 2018 | 1014 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2018 | 556 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2015 | 459 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2006 | 95 | 0.030 |
Why?
|
Workflow | 1 | 2019 | 821 | 0.030 |
Why?
|
Antimetabolites | 1 | 2014 | 126 | 0.030 |
Why?
|
Monocrotaline | 1 | 2013 | 28 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2018 | 825 | 0.030 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2001 | 1203 | 0.030 |
Why?
|
Histones | 2 | 2018 | 2551 | 0.030 |
Why?
|
Drug Interactions | 1 | 2018 | 1468 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2014 | 6093 | 0.030 |
Why?
|
Estrogen Receptor Modulators | 1 | 2012 | 65 | 0.030 |
Why?
|
G1 Phase | 1 | 2014 | 420 | 0.030 |
Why?
|
Cyclization | 1 | 2011 | 66 | 0.030 |
Why?
|
rab GTP-Binding Proteins | 1 | 2014 | 236 | 0.030 |
Why?
|
Cell Line | 2 | 2009 | 16576 | 0.030 |
Why?
|
Models, Organizational | 1 | 2016 | 583 | 0.030 |
Why?
|
Genomic Instability | 1 | 2016 | 689 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2012 | 585 | 0.030 |
Why?
|
Cell Survival | 2 | 2018 | 6035 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2425 | 0.030 |
Why?
|
Click Chemistry | 1 | 2012 | 102 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2001 | 2918 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2015 | 1602 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11689 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1634 | 0.020 |
Why?
|
Mice, SCID | 1 | 2016 | 2787 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2394 | 0.020 |
Why?
|
Luciferases | 1 | 2012 | 750 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2002 | 3638 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2743 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1103 | 0.020 |
Why?
|
Cell Line, Transformed | 2 | 2001 | 976 | 0.020 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2013 | 453 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2016 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2009 | 201 | 0.020 |
Why?
|
Cyclooxygenase 2 | 2 | 2003 | 630 | 0.020 |
Why?
|
Ketoglutaric Acids | 1 | 2009 | 83 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2012 | 1220 | 0.020 |
Why?
|
Glycolysis | 1 | 2013 | 810 | 0.020 |
Why?
|
Tubulin | 1 | 2013 | 759 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2099 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2001 | 4647 | 0.020 |
Why?
|
Reference Standards | 1 | 2012 | 996 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9504 | 0.020 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2009 | 286 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1603 | 0.020 |
Why?
|
Metabolomics | 1 | 2016 | 1392 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2129 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40875 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2013 | 939 | 0.020 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2006 | 32 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2009 | 683 | 0.020 |
Why?
|
GTP-Binding Protein gamma Subunits | 1 | 2006 | 31 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2538 | 0.020 |
Why?
|
Pyrroles | 1 | 2013 | 1172 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2008 | 468 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2034 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2014 | 849 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 7099 | 0.020 |
Why?
|
Caspases | 1 | 2009 | 949 | 0.020 |
Why?
|
Cell Membrane | 1 | 2016 | 3879 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2006 | 369 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2014 | 2008 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 403 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2003 | 19910 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6552 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 620 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4699 | 0.020 |
Why?
|
Estrogens | 1 | 2012 | 1529 | 0.020 |
Why?
|
Echocardiography | 1 | 2018 | 5044 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2973 | 0.020 |
Why?
|
Male | 7 | 2013 | 350324 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 3964 | 0.020 |
Why?
|
Estradiol | 1 | 2012 | 1978 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2009 | 814 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2004 | 150 | 0.020 |
Why?
|
Collagen | 2 | 2004 | 2667 | 0.020 |
Why?
|
Aged | 3 | 2013 | 162448 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 3485 | 0.020 |
Why?
|
Genes, src | 1 | 2003 | 52 | 0.020 |
Why?
|
Cell Death | 1 | 2009 | 1724 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2006 | 752 | 0.020 |
Why?
|
RNA, Ribosomal | 1 | 2004 | 238 | 0.020 |
Why?
|
Allantois | 1 | 2003 | 32 | 0.020 |
Why?
|
Transforming Growth Factor alpha | 1 | 2003 | 137 | 0.010 |
Why?
|
Nitrobenzenes | 1 | 2003 | 79 | 0.010 |
Why?
|
Drug Design | 1 | 2008 | 1099 | 0.010 |
Why?
|
Clinical Competence | 1 | 2019 | 4630 | 0.010 |
Why?
|
Chorion | 1 | 2003 | 116 | 0.010 |
Why?
|
Middle Aged | 3 | 2013 | 214639 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9377 | 0.010 |
Why?
|
Laminin | 1 | 2004 | 418 | 0.010 |
Why?
|
Piperazines | 1 | 2013 | 2524 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 15059 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2016 | 5102 | 0.010 |
Why?
|
Solubility | 1 | 2004 | 1136 | 0.010 |
Why?
|
Mitosis | 1 | 2007 | 1248 | 0.010 |
Why?
|
GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2001 | 32 | 0.010 |
Why?
|
Olfactory Mucosa | 1 | 2002 | 102 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8545 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 2 | 2003 | 2883 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2578 | 0.010 |
Why?
|
Cyclooxygenase 1 | 1 | 2001 | 111 | 0.010 |
Why?
|
Chick Embryo | 1 | 2003 | 971 | 0.010 |
Why?
|
Proteoglycans | 1 | 2004 | 831 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2001 | 297 | 0.010 |
Why?
|
Neurosecretory Systems | 1 | 2002 | 237 | 0.010 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 391 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 333 | 0.010 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2001 | 294 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2005 | 58323 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 2003 | 723 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3947 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2004 | 891 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 2807 | 0.010 |
Why?
|
Biomedical Research | 1 | 2016 | 3268 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2004 | 653 | 0.010 |
Why?
|
Down-Regulation | 1 | 2007 | 3066 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 547 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 510 | 0.010 |
Why?
|
Capillaries | 1 | 2003 | 777 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22665 | 0.010 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2002 | 412 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7954 | 0.010 |
Why?
|
Liver | 1 | 2015 | 7594 | 0.010 |
Why?
|
Morphogenesis | 1 | 2003 | 779 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 1928 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 4040 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2210 | 0.010 |
Why?
|
GTP Phosphohydrolases | 1 | 2001 | 510 | 0.010 |
Why?
|
Oxygen | 1 | 2009 | 4162 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2001 | 2086 | 0.010 |
Why?
|
DNA Primers | 1 | 2002 | 2979 | 0.010 |
Why?
|
Rats | 1 | 2013 | 24860 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1974 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1743 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2004 | 11655 | 0.010 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 10605 | 0.010 |
Why?
|
Glycoproteins | 1 | 2003 | 2306 | 0.010 |
Why?
|
Cell Lineage | 1 | 2004 | 2594 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2003 | 8047 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4893 | 0.010 |
Why?
|
Prostate | 1 | 2002 | 1592 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2001 | 3265 | 0.010 |
Why?
|
Trans-Activators | 1 | 2004 | 3047 | 0.010 |
Why?
|
Colon | 1 | 2002 | 1759 | 0.010 |
Why?
|
Adult | 2 | 2013 | 212266 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2003 | 2939 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13213 | 0.010 |
Why?
|
Brain | 1 | 2018 | 25206 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 11201 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2001 | 3034 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4586 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5947 | 0.010 |
Why?
|
Young Adult | 1 | 2013 | 56226 | 0.000 |
Why?
|